# Batch 02 Partial-10 Multi-Module / Note / PDF Reaudit Report

Generated: `2026-06-21`  
Coverage: the next confirmed-core flat positions after `ASD-0077`, skipping `ASD-0078` and `ASD-0082` because they are not confirmed-core, and closing `ASD-0079`, `ASD-0080`, `ASD-0081`, and `ASD-0083`.  
Mode: `Batch 02 partial-10`; this closeout used the plan-defined multi-agent team structure: `Evidence-Agent-A/B/C` for read-only first-hand evidence collection, `Classification-Reviewer` for independent module adjudication, and `Main Controller` for final write-back.

## 1. What Was Closed In This Partial Slice

- `ASD-0079` (`DrugAgent: Multi-Agent Large Language Model-Based Reasoning for Drug-Target Interaction Prediction`) now has an archived local arXiv PDF and remains a stable single-module `07` record.
- `ASD-0080` (`System of agentic ai for the discovery of metal-organic frameworks`) now has an archived local arXiv PDF and remains a stable single-module `04` record.
- `ASD-0081` (`Crispr-gpt: An llm agent for automated design of gene-editing experiments`) now has an archived local PDF and remains a stable single-module `06` record after full-text recheck against the published-version metadata.
- `ASD-0083` (`Robin: A multi-agent system for automating scientific discovery`) now has an archived local arXiv PDF and is formally landed as a relaxed multi-module `06;07` record.

## 2. Record-Level Outcomes

| ID | Title | Authoritative modules or bucket | PDF / source status | Outcome |
|---|---|---|---|---|
| ASD-0079 | DrugAgent: Multi-Agent Large Language Model-Based Reasoning for Drug-Target Interaction Prediction | `07` | archived arXiv PDF | keep single-module biomedical / drug-discovery record |
| ASD-0080 | System of agentic ai for the discovery of metal-organic frameworks | `04` | archived arXiv PDF | keep single-module materials-science / MOF record |
| ASD-0081 | Crispr-gpt: An llm agent for automated design of gene-editing experiments | `06` | archived local PDF + journal metadata recheck | keep single-module life-science / gene-editing experiment-design record |
| ASD-0083 | Robin: A multi-agent system for automating scientific discovery | `06;07` | archived arXiv PDF | land multi-module life-science plus medical / therapeutic-discovery record |

## 3. Boundary Notes

`ASD-0079`  
The first-hand full text keeps the paper firmly inside biomedical drug discovery. The validated object is DTI prediction with biomedical evidence integration, so there is no reason to drift toward `01.04` or force a chemistry-primary rewrite.

`ASD-0080`  
Although the workflow contains strong chemistry and synthesis internals, the concrete object remains MOFs and porous materials with generation, screening, and synthesis validation. Under the current object-first rule, `04` stays stable.

`ASD-0081`  
This paper sits near the `06 / 07` boundary because of its biomedical framing, but the directly validated object is CRISPR gene-editing experiment design and biological validation rather than disease- or therapy-centered medical evaluation. The main-controller close remains `06`.

`ASD-0083`  
This is the main landed classification change in the slice. The dry AMD therapeutic-discovery object anchors `07`, while the RPE phagocytosis assays, RNA-seq analysis, and ABCA1 mechanism evidence independently support `06`. The relaxed multi-module rule therefore supports `06;07` rather than a single-class record.

## 4. Partial Statistics

- Closed records in this partial slice: `4`
- Archived local PDFs confirmed in this slice: `4`
- Notes updated: `4`
- Master rows updated: `4`
- Final distribution inside this partial slice: `07 x1`, `04 x1`, `06 x1`, `06;07 x1`

## 5. Multi-Agent Audit Trace

- `Evidence-Agent-A` collected the first-hand evidence for `ASD-0079`, `ASD-0080`, `ASD-0081`, and `ASD-0083` within a larger 30-paper evidence round.
- `Classification-Reviewer` independently confirmed the landed outcomes:
  - `ASD-0079 -> 07`
  - `ASD-0080 -> 04`
  - `ASD-0081 -> 06`
  - `ASD-0083 -> 06;07`
- No paper in this partial slice required a `safety_skip` or `not accessed due to safety` marker.

## 6. Next Step

Continue the same multi-agent evidence round for the remaining papers already reviewed in the current 30-paper block, starting from `ASD-0084`.
